KR780000248B1 - Process for preparation of glycosidehydrolases inhibitors - Google Patents

Process for preparation of glycosidehydrolases inhibitors

Info

Publication number
KR780000248B1
KR780000248B1 KR7101871A KR710001871A KR780000248B1 KR 780000248 B1 KR780000248 B1 KR 780000248B1 KR 7101871 A KR7101871 A KR 7101871A KR 710001871 A KR710001871 A KR 710001871A KR 780000248 B1 KR780000248 B1 KR 780000248B1
Authority
KR
South Korea
Prior art keywords
glycosidehydrolases
inhibitors
preparation
glycosidehydrolases inhibitors
Prior art date
Application number
KR7101871A
Other languages
English (en)
Korean (ko)
Inventor
W Puls
W Frommer
D Schmidt
D Schaefer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of KR780000248B1 publication Critical patent/KR780000248B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/907—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
KR7101871A 1970-12-28 1971-12-27 Process for preparation of glycosidehydrolases inhibitors KR780000248B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (de) 1970-12-28 1970-12-28 Inhibitoren für Glykosidhydrolasen aus Actinomyceten

Publications (1)

Publication Number Publication Date
KR780000248B1 true KR780000248B1 (en) 1978-07-06

Family

ID=5792372

Family Applications (1)

Application Number Title Priority Date Filing Date
KR7101871A KR780000248B1 (en) 1970-12-28 1971-12-27 Process for preparation of glycosidehydrolases inhibitors

Country Status (28)

Country Link
US (1) US3876766A (xx)
JP (3) JPS5734996B1 (xx)
KR (1) KR780000248B1 (xx)
AR (1) AR193370A1 (xx)
AT (1) AT330122B (xx)
AU (1) AU461521B2 (xx)
BE (1) BE777387A (xx)
BG (3) BG25654A3 (xx)
CA (1) CA979833A (xx)
CH (1) CH594051A5 (xx)
CS (1) CS167961B2 (xx)
DD (1) DD99395A5 (xx)
DE (1) DE2064092C2 (xx)
DK (1) DK139533C (xx)
ES (1) ES398358A1 (xx)
FI (1) FI49774C (xx)
FR (1) FR2120073B1 (xx)
GB (1) GB1374751A (xx)
IE (1) IE35920B1 (xx)
IL (1) IL38441A (xx)
LU (1) LU64319A1 (xx)
NL (1) NL175199C (xx)
NO (1) NO135873C (xx)
PL (1) PL82900B1 (xx)
RO (3) RO61400A (xx)
SE (1) SE398357B (xx)
SU (1) SU454750A3 (xx)
ZA (1) ZA718677B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209834C3 (de) * 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Herstellung von Saccharase-Inhibitoren
DE2209832C3 (de) * 1972-03-01 1979-03-29 Bayer Ag, 5090 Leverkusen Herstellung von Saccharaseinhibitoren
DE2209833C3 (de) * 1972-03-01 1978-06-01 Bayer Ag, 5090 Leverkusen Herstellung eines Amylaseinhibitors
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (fr) * 1976-01-22 1977-08-19 Rhone Poulenc Ind Nouvel inhibiteur de glyco-hydrolases et sa preparation par culture d'un streptomyces
DE2658563A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Inhibitoren fuer glykosid-hydrolasen aus bacillen
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
JPS62160696A (ja) * 1986-01-07 1987-07-16 シャープ株式会社 電子式自動点滅器
ES2056801T3 (es) * 1986-08-13 1994-10-16 Hoechst Ag Oxirano-seudooligosacaridos, procedimiento para su preparacion, su utilizacion y preparados farmaceuticos.
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (de) * 1995-03-02 1996-10-31 Bayer Ag Acarbose-Biosynthesegene aus Actinoplanes sp., Verfahren zu ihrer Isolierung sowie ihre Verwendung
EP0796915A3 (de) * 1996-03-22 1999-04-14 Bayer Ag Verfahren zur Herstellung sowie zur Verwendung von Acarviosyl-Transferase bei der Umwandlung von Acarbose-Homologen in Acarbose, zur Herstellung von Acarbose-Homologen
DE19637591A1 (de) * 1996-09-13 1998-03-19 Bayer Ag Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose
WO2001030796A1 (en) 1999-10-28 2001-05-03 Chong Kun Dang Pharmaceutical Corp. A process for preparing acarbose with high purity
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
IN2014CN04155A (xx) 2011-12-08 2015-07-17 Bayer Ip Gmbh
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
JP2022553183A (ja) 2019-10-16 2022-12-22 バイエル・アクチエンゲゼルシヤフト アカルボースの改善された形成方法
MX2022011717A (es) 2020-03-23 2022-12-07 Bay State Milling Company Prueba rapida de pureza de semilla de trigo con alta amilosa.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Also Published As

Publication number Publication date
BG26003A4 (xx) 1979-01-12
JPS5734996B1 (xx) 1982-07-26
NL175199C (nl) 1984-10-01
DD99395A5 (xx) 1973-08-05
SU454750A3 (ru) 1974-12-25
DE2064092C2 (de) 1983-06-01
JPS57150396A (en) 1982-09-17
US3876766A (en) 1975-04-08
RO63065A (fr) 1979-02-15
ES398358A1 (es) 1974-09-01
SE398357B (sv) 1977-12-19
ATA1111571A (de) 1975-09-15
CS167961B2 (xx) 1976-05-28
JPS57150395A (en) 1982-09-17
LU64319A1 (xx) 1972-06-13
DE2064092A1 (de) 1972-07-20
JPS6216638B2 (xx) 1987-04-14
IE35920B1 (en) 1976-06-23
FI49774B (xx) 1975-06-30
JPS6234396B2 (xx) 1987-07-27
NO135873C (xx) 1977-06-15
FR2120073B1 (xx) 1975-12-26
CH594051A5 (xx) 1977-12-30
CA979833A (en) 1975-12-16
GB1374751A (en) 1974-11-20
FI49774C (fi) 1975-10-10
AU3721471A (en) 1973-09-27
RO61400A (xx) 1977-01-15
NL175199B (nl) 1984-05-01
AT330122B (de) 1976-06-10
BG26002A4 (xx) 1979-01-12
DK139533B (da) 1979-03-05
BG25654A3 (xx) 1978-11-10
FR2120073A1 (xx) 1972-08-11
ZA718677B (en) 1972-09-27
DK139533C (da) 1979-08-20
AR193370A1 (es) 1973-04-23
IE35920L (en) 1972-06-28
AU461521B2 (en) 1975-05-29
BE777387A (fr) 1972-06-28
RO63064A (fr) 1978-06-15
IL38441A (en) 1974-10-22
NO135873B (xx) 1977-03-07
NL7117893A (xx) 1972-06-30
PL82900B1 (xx) 1975-10-31
IL38441A0 (en) 1972-02-29

Similar Documents

Publication Publication Date Title
KR780000248B1 (en) Process for preparation of glycosidehydrolases inhibitors
PH11550A (en) Process for the preparation of 7-acyl-3-cephem-4-carboxylic acids
JPS5217449A (en) Process for manufacture of 155alkylprostaglandin
YU34533B (en) Process for preparing novel derivatives of adenosin-5-carboxylic acid
ZA707493B (en) Process for the preparation of 3-propionyl-salicylic acid
ZA715124B (en) Process for the preparation of 4-oxocapronitrile
JPS53147082A (en) Method of produing fluoropyrimidine compound
ZA711002B (en) Process for the continuous preparation of dichloropropanols
CS180570B2 (en) Method for production of erythromycylamines
CS193012B2 (en) Method of preparing 3-halogene-6-hydroxy-2-pyridones
PH9228A (en) Process for the preparation of 3-phenyl-5-t-butyl-2-oxadiazolones
IL38014A0 (en) Process for preparation of new antibiotic derivatives
EG10311A (en) Process for preparation of pyroglutamylpeptide used for thyraid gland
ZA718479B (en) Process for the preparation of benzamide derivatives
ZA717432B (en) Process for the preparation of heterocyclic compounds
AU3246871A (en) Process for the preparation of isoprene
GB1364913A (en) Process for the preparation of isoprene
EG10648A (en) Process for preparation of n-isopropylaniline
EG10440A (en) Process for the preparation of des-phenylalamin b1-insuli
EG10524A (en) Process for preparation of penicillamin
ZA708476B (en) Process for the preparation of isoxazolylethyl substituted tetrahydropyranols
CS179963B2 (en) Method of preparing 3-isoxazolylcarbonylureides
YU204771A (en) Process for preparing anilides of dioxocyclohexanecarboxylic acid
IL38029A0 (en) Process for the preparation of 14-anhydrobufaline
ZA716087B (en) New process for the preparation of substituted cobamides